Helena Ildiko Saxon

Ms. Helena Ildiko Saxon is Chief Financial Officer at Investor AB, Independent Director at Swedish Orphan Biovitrum AB, and Chief Financial Officer & Member-Management Group at Investor AB. She is on the Board of Directors at Swedish Orphan Biovitrum AB, Aleris Holding AB, and Mölnlycke Health Care Group AB. Ms. Saxon was previously employed as an Analyst by Goldman Sachs Ltd., Chief Executive Officer by Prosensa Holding NV, Chief Financial Officer by Hallvarsson & Halvarsson AB, Chief Financial Officer by Syncron International AB, and Deputy Director by Incentive AB. She received her graduate degree from the Stockholm School of Economics and an MBA from the Stockholm School of Economics.